Author

Cristiano Piron

Institution: Medical Decision Modeling (United States)

Observed institution: Medical Decision Modeling (United States)

ORCID: 0009-0008-2236-8873

Observed ORCID: 0009-0008-2236-8873

OpenAlex ID: A5095065097

Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene–related peptide monoclonal antibodies

2024 · Jessica Ailani, Anjana Lalla, et al. · Cephalalgia · 5

Network Meta-Analysis Comparing Efficacy and Safety Outcomes of Atogepant, Rimegepant, and Galcanezumab in Patients with Episodic Migraine After Including CHALLENGE-MIG Trial (P9-12.007)

2025 · Jessica Ailani, Pranav Gandhi, et al. · Neurology

Benefit-Risk Assessment Based on Number Needed to Treat and Number Needed to Harm: Atogepant vs Calcitonin Gene–Related Peptide Monoclonal Antibodies (P5-12.007)

2024 · Simona Sacco, Anjana Lalla, et al. · Neurology

Works count: 3

Citation count: 5

H-index: 1

I10-index: